Myriam Curet Sells 4,500 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) Stock

Key Points

• Myriam Curet, Executive Vice President of Intuitive Surgical, sold 4,500 shares of the company’s stock for a total of $2,216,160, representing a significant 92.73% decrease in their ownership.
• Intuitive Surgical reported a 21.4% year-over-year increase in quarterly revenue to $2.44 billion, significantly exceeding analyst expectations.
• Analysts have set new price targets for Intuitive Surgical, with Citigroup raising its target from $590 to $650, indicating strong confidence in the stock's future performance.

Intuitive Surgical, Inc. (NASDAQ:ISRG - Get Free Report) EVP Myriam Curet sold 4,500 shares of the business's stock in a transaction on Friday, July 25th. The stock was sold at an average price of $492.48, for a total value of $2,216,160.00. Following the sale, the executive vice president directly owned 353 shares in the company, valued at $173,845.44. This trade represents a 92.73% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Intuitive Surgical Stock Up 1.5%

Intuitive Surgical stock traded up $7.25 during trading hours on Friday, hitting $495.86. The stock had a trading volume of 1,870,941 shares, compared to its average volume of 1,842,693. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $616.00. The company has a 50-day moving average of $529.86 and a two-hundred day moving average of $535.07. The company has a market cap of $177.76 billion, a PE ratio of 69.16, a price-to-earnings-growth ratio of 5.53 and a beta of 1.64.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%. The business had revenue of $2.44 billion during the quarter, compared to analysts' expectations of $2.35 billion. During the same period in the prior year, the firm posted $1.78 EPS. Intuitive Surgical's quarterly revenue was up 21.4% compared to the same quarter last year. As a group, analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on the company. Truist Financial upped their price target on Intuitive Surgical from $590.00 to $600.00 and gave the company a "buy" rating in a research report on Wednesday. Erste Group Bank restated a "hold" rating on shares of Intuitive Surgical in a research note on Wednesday. BTIG Research boosted their target price on Intuitive Surgical from $566.00 to $571.00 and gave the company a "buy" rating in a research note on Wednesday. Barclays lowered their target price on Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a research note on Thursday, April 24th. Finally, Deutsche Bank Aktiengesellschaft downgraded Intuitive Surgical from a "hold" rating to a "sell" rating and lowered their target price for the company from $515.00 to $440.00 in a research note on Monday, June 9th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have assigned a buy rating to the stock. According to MarketBeat.com, Intuitive Surgical presently has a consensus rating of "Moderate Buy" and a consensus price target of $592.05.

Hedge Funds Weigh In On Intuitive Surgical

Hedge funds have recently modified their holdings of the stock. Vanguard Group Inc. boosted its position in Intuitive Surgical by 1.4% in the 1st quarter. Vanguard Group Inc. now owns 32,665,531 shares of the medical equipment provider's stock valued at $16,178,258,000 after buying an additional 453,335 shares during the last quarter. Geode Capital Management LLC boosted its position in Intuitive Surgical by 3.2% in the 4th quarter. Geode Capital Management LLC now owns 7,756,727 shares of the medical equipment provider's stock valued at $4,039,200,000 after buying an additional 243,802 shares during the last quarter. Norges Bank bought a new position in Intuitive Surgical in the 4th quarter valued at $2,401,493,000. Invesco Ltd. boosted its position in Intuitive Surgical by 1.7% in the 1st quarter. Invesco Ltd. now owns 4,219,974 shares of the medical equipment provider's stock valued at $2,090,027,000 after buying an additional 71,794 shares during the last quarter. Finally, Northern Trust Corp boosted its position in Intuitive Surgical by 0.3% in the 1st quarter. Northern Trust Corp now owns 3,631,281 shares of the medical equipment provider's stock valued at $1,798,465,000 after buying an additional 11,988 shares during the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.